← back to search

Jiaqing Xiang

Fudan University Shanghai Cancer Center · CN
Area of research
Surgery · Pulmonary and Respiratory Medicine
Research interest
Research interests include Esophageal Cancer Research and Treatment, Lung Cancer Diagnosis and Treatment, Lung Cancer Treatments and Mutations, and Head and Neck Cancer Studies.
h-index
38
citations
5,932
works
178
NIH funding
primary concept
email

Recent publications

Phase III Study of Mediastinal Lymph Node Dissection for Ground Glass Opacity–Dominant Lung Adenocarcinoma
Journal of Clinical Oncology 2025cited by 12position: middledoi
Genomic and immune heterogeneity of multiple synchronous lung adenocarcinoma at different developmental stages
Nature Communications 2024cited by 14position: middledoi
Selective Mediastinal Lymph Node Dissection Strategy for Clinical T1N0 Invasive Lung Cancer: A Prospective, Multicenter, Clinical Trial
Journal of Thoracic Oncology 2023cited by 60position: middledoi
Radiologic Identification of Pathologic Tumor Invasion in Patients With Lung Adenocarcinoma
JAMA Network Open 2023cited by 18position: middledoi
Prognostic value of recurrence pattern in locally advanced esophageal squamous cell carcinoma: Results from the phase III trial NEOCRTEC5010
Journal of Thoracic and Cardiovascular Surgery 2022cited by 25position: middledoi
Long-term Efficacy of Neoadjuvant Chemoradiotherapy Plus Surgery for the Treatment of Locally Advanced Esophageal Squamous Cell Carcinoma
JAMA Surgery 2021cited by 339position: middledoi
Impact of Lymph Node Dissection on Survival After Neoadjuvant Chemoradiotherapy for Locally Advanced Esophageal Squamous Cell Carcinoma
Annals of Surgery 2021cited by 48position: middledoi
Pathological complete response after neoadjuvant treatment determines survival in esophageal squamous cell carcinoma patients (NEOCRTEC5010)
Annals of Translational Medicine 2021cited by 40position: middledoi
Expert consensus on perioperative immunotherapy for local advanced non-small cell lung cancer
Translational Lung Cancer Research 2021cited by 22position: middledoi
Esophagectomy With Three-Field Versus Two-Field Lymphadenectomy for Middle and Lower Thoracic Esophageal Cancer: Long-Term Outcomes of a Randomized Clinical Trial
Journal of Thoracic Oncology 2020cited by 114position: middledoi
Recurrence patterns after neoadjuvant chemoradiotherapy compared with surgery alone in oesophageal squamous cell carcinoma: results from the multicenter phase III trial NEOCRTEC5010
European Journal of Cancer 2020cited by 104position: middledoi
Immunoscore Signature Predicts Postoperative Survival and Adjuvant Chemotherapeutic Benefits in Esophageal Squamous Cell Carcinoma.
2020cited by 3position: contributordoi
Lung Adenocarcinomas Manifesting as Radiological Part-Solid Nodules Define a Special Clinical Subtype
Journal of Thoracic Oncology 2019cited by 282position: middledoi
Genomic and immune profiling of pre-invasive lung adenocarcinoma
Nature Communications 2019cited by 275position: middledoi
Distinct Prognostic Factors in Patients with Stage I Non–Small Cell Lung Cancer with Radiologic Part-Solid or Solid Lesions
Journal of Thoracic Oncology 2019cited by 205position: middledoi
The lymph node status and histologic subtypes influenced the effect of postoperative radiotherapy on patients with N2 positive IIIA non-small cell lung cancer.
2019cited by 32position: contributordoi
Neoadjuvant Chemoradiotherapy Followed by Surgery Versus Surgery Alone for Locally Advanced Squamous Cell Carcinoma of the Esophagus (NEOCRTEC5010): A Phase III Multicenter, Randomized, Open-Label Clinical Trial
Journal of Clinical Oncology 2018cited by 964position: middledoi
Development and Validation of Web-Based Nomograms to Precisely Predict Conditional Risk of Site-Specific Recurrence for Patients With Completely Resected Non-small Cell Lung Cancer
CHEST Journal 2018cited by 50position: middledoi
Comparative genomic analysis of esophageal squamous cell carcinoma between Asian and Caucasian patient populations
Nature Communications 2017cited by 129position: middledoi
Polymorphisms in the <i><scp>AKT</scp>1</i> and <i><scp>AKT</scp>2</i> genes and oesophageal squamous cell carcinoma risk in an Eastern Chinese population
Journal of Cellular and Molecular Medicine 2016cited by 33position: middledoi
Genetic variants in miR-196a2 and miR-499 are associated with susceptibility to esophageal squamous cell carcinoma in Chinese Han population
Tumor Biology 2015cited by 43position: middledoi
Risk factors for predicting the occult nodal metastasis in T1–2N0M0 NSCLC patients staged by PET/CT: Potential value in the clinic
Lung Cancer 2013cited by 68position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Yihua Sun · Fudan University7 papers (2018–2025)Yuan Li · Shihezi University6 papers (2018–2025)Yawei Zhang · Shanghai Medical College of Fudan University6 papers (2018–2023)Hong Hu · Tonghua Normal University6 papers (2018–2023)Haiquan Chen · Shanghai Medical College of Fudan University6 papers (2013–2023)Shengping Wang · Fudan University5 papers (2019–2025)Fangqiu Fu · Shanghai Medical College of Fudan University4 papers (2019–2025)Ting Ye · Fudan University4 papers (2019–2023)Yang Zhang · Fudan University4 papers (2018–2023)Haoxuan Wu · Fudan University3 papers (2023–2025)Bin Qian · Shanghai Medical College of Fudan University3 papers (2023–2025)Xuxia Shen · Fudan University3 papers (2019–2023)Wentao Fang · Henan Cancer Hospital2 papers (2020–2021)Chaoqiang Deng · Shanghai Medical College of Fudan University2 papers (2023–2025)Qingyuan Huang · Shanghai Medical College of Fudan University2 papers (2023–2025)Jin Li · Xinjiang University2 papers (2015–2016)Hui Liu · Sun Yat-sen University2 papers (2020–2021)Linhong Deng · Changzhou University2 papers (2019–2019)Yuping Chen · Nanjing University of Finance and Economics2 papers (2020–2021)Yue Zhao · Qilu Hospital of Shandong University2 papers (2019–2019)